View The Document

Accession Number:

AD1155038

Title:

The Evolving AML Genomic Landscape: Therapeutic Implications

Author(s):

Author Organization(s):

Report Date:

2021-01-01

Abstract:

AML studies has largely shifted from dissecting large genomic datasets to determine how they could be translated into clinical practice, towards applying genomic data to clinical cases, and tailoring drug treatments to individual patients based on genomic signatures. In the future, it may be possible to individualize treatment regimens. Stephano. The Evolving AML Genomic Landscape: Therapeutic Implications, Current Cancer Drug Targets, 2020, 20(7): 532-544.

Pages:

27

DOI:

10.2174/1568009620666200424150321

File Size:

0.73MB

Descriptors:

Identifiers:

SubjectCategory:

Distribution Statement:

Approved For Public Release

View The Document